97693879 - ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES

Information

• Trademark
• 97693879

• Source

• Serial Number

  97693879

• Registration Number

  7423244

• International Classifications

  • 35 - Advertising
  • 36 - Insurance
  • 44 - Medical services

• Filing Date

  November 28, 2022
  a year ago

• Registration Date

  June 18, 2024
  9 days ago

• Transaction Date

  June 18, 2024
  9 days ago

• Status Date

  June 18, 2024
  9 days ago

• Published for Opposition Date

  August 08, 2023
  10 months ago

• Location Date

  May 13, 2024
  a month ago

• First Use Anywhere Date

  January 01, 2024
  5 months ago

• First Use In Commerce Date

  January 01, 2024
  5 months ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MORENO, PAUL A

• Attorney Docket Number

  32827-50494

  Attorney Name

  Nicole Kinsley, Esq.

  Law Office Assigned Location Code

  L30

• Owners

  • Immunogen, Inc.

Case File Statements

• DM0000: The mark consists of the word "ELAHERE" in block capital letters, stacked above "mirvetuximab soravtansine", "injection 100 mg", and "SUPPORT SERVICES", with the design of a half circle sunburst to the left of these words made up of trapezoid-shaped lines, each divided into three sections of different shades, arrayed around the upper left corner of the first "E" in "ELAHERE".
• PM0001: ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE ZERO ZERO MG SUPPORT SERVICES; ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE HUNDRED MG SUPPORT SERVICES
• GS0361: Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products
• GS0441: Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes
• DS0000: "SUPPORT SERVICES" AND "MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG"

Case File Event Statements

• 12/21/2022 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 12/1/2022 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 12/20/2022 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/26/2023 - a year ago

  4 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 5/21/2023 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 5/23/2023 - a year ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/23/2023 - a year ago

  7 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/23/2023 - a year ago

  8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/30/2023 - 12 months ago

  12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/30/2023 - 12 months ago

  13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/30/2023 - 12 months ago

  14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/30/2023 - 12 months ago

  15 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 6/30/2023 - 12 months ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/30/2023 - 12 months ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/30/2023 - 12 months ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/3/2023 - 12 months ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/19/2023 - 11 months ago

  17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/8/2023 - 10 months ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/8/2023 - 10 months ago

  19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/3/2023 - 8 months ago

  20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/8/2024 - 3 months ago

  27 - USE AMENDMENT FILED Type: IUAF

• 3/8/2024 - 3 months ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/8/2024 - 3 months ago

  23 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/8/2024 - 3 months ago

  22 - SOU EXTENSION 1 FILED Type: EXT1

• 4/1/2024 - 2 months ago

  28 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 5/13/2024 - a month ago

  30 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 5/13/2024 - a month ago

  29 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 3/8/2024 - 3 months ago

  24 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 3/9/2024 - 3 months ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/1/2024 - 2 months ago

  26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 6/18/2024 - 9 days ago

  31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/18/2024 - 9 days ago

  32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC